SCHNELL DAVID

CIK 00011620609 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001162060

Recent Transactions

50 trades

Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-05-20+16,806→ 16,806 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-05-15+24,000→ 24,000 total
Conversion
NGM BIOPHARMACEUTICALS INC
Series D Preferred Stock
2019-04-08−100,000→ 0 total
Conversion
NGM BIOPHARMACEUTICALS INC
Common Stock
2019-04-08+4,925,000→ 4,925,000 total
Conversion
NGM BIOPHARMACEUTICALS INC
Series B Preferred Stock
2019-04-08−1,300,000→ 0 total
Conversion
NGM BIOPHARMACEUTICALS INC
Series C Preferred Stock
2019-04-08−525,000→ 0 total
Conversion
NGM BIOPHARMACEUTICALS INC
Series A Preferred Stock
2019-04-08−3,000,000→ 0 total
Other
Vitae Pharmaceuticals, Inc
Common Stock
2015-03-24+20,357→ 28,237 total
Other
Vitae Pharmaceuticals, Inc
Common Stock
2015-03-24+20,357→ 32,584 total
Other
Vitae Pharmaceuticals, Inc
Common Stock
2015-03-24−900,383→ 1,672,140 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,530,269→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+671,807→ 2,572,523 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+76,949→ 1,900,716 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+102,301→ 395,799 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Award
KYTHERA BIOPHARMACEUTICALS INC
Stock Option (right to buy)
2013-06-04+6,618→ 6,618 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Common Stock
2012-10-16+1,476→ 1,476 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Common Stock
2012-10-16+118,013→ 1,914,566 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Series D Preferred Stock
2012-10-16−118,013→ 0 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Common Stock
2012-10-16+469,926→ 1,796,553 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Common Stock
2012-10-16+1,325,151→ 1,326,627 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Series A Preferred Stock
2012-10-16−1,476→ 0 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Series B Preferred Stock
2012-10-16−1,314,831→ 0 total
Conversion
KYTHERA BIOPHARMACEUTICALS INC
Series C Preferred Stock
2012-10-16−469,926→ 0 total
Award
KYTHERA BIOPHARMACEUTICALS INC
Stock Option (right to buy)
2012-10-10+5,672→ 5,672 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2010-10-28−5,000→ 0 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2010-10-28−5,000→ 0 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−1,829,765→ 1,829,765 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−27,866→ 27,866 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2010-10-28−12,500→ 0 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2010-10-28−5,000→ 0 total
Disposition to Issuer
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2010-10-28−5,000→ 0 total
Award
Trubion Pharmaceuticals, Inc
Stock option (right to purchase)
2009-05-27+5,000→ 5,000 total
Other
HANSEN MEDICAL INC
Common Stock
2007-11-02−886,500→ 1,366,717 total
Other
HANSEN MEDICAL INC
Common Stock
2007-11-02−13,500→ 20,812 total
Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2007-06-05+2,198,582→ 2,198,582 total
Sale
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2007-06-05$15.00/sh−97→ 33,608 total
Exercise of In-Money
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2007-06-05$6.38/sh+227→ 33,705 total
Exercise of In-Money
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2007-06-05$6.38/sh+14,892→ 2,213,474 total
Exercise of In-Money
AMICUS THERAPEUTICS, INC.$FOLD
Warrant to purchase Series B Preferred Stock
2007-06-05−227
Exercise of In-Money
AMICUS THERAPEUTICS, INC.$FOLD
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892
Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Series B Convertible Preferred Stock
2007-06-05−978,562
Sale
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2007-06-05$15.00/sh−6,330→ 2,207,144 total
Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Series D Convertible Preferred Stock
2007-06-05−3,334
Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Series C Convertible Preferred Stock
2007-06-05−15,242
Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Series B Convertible Preferred Stock
2007-06-05−14,902

Companies

Recent Filings

Address

C/O PROSPECT VENTURE PARTNERS 435 TASSO STREET, SUITE 200

PALO ALTO, CA, 94301

View on SEC.gov